This topic contains a solution. Click here to go to the answer

Author Question: Boyce-Codd normal form (BCNF) a non-key field cannot determine a part of the primary key. ... (Read 91 times)

Coya19@aol.com

  • Hero Member
  • *****
  • Posts: 601
Boyce-Codd normal form (BCNF) a non-key field cannot determine a part of the primary key.
 
  Indicate whether the statement is true or false

Question 2

In marketing transactions, the fact that customers who buy product X also buy product Y creates a ________ opportunity. That is, If they're buying X, sell them Y or If they're buying Y, sell them X.
 
  A) cross-selling
  B) value added selling
  C) break-even
  D) double-sales



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Fayaz00962

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

TRUE

Answer to Question 2

A




Coya19@aol.com

  • Member
  • Posts: 601
Reply 2 on: Jul 7, 2018
:D TYSM


phuda

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library